Matthew Wikler - 30 Sep 2021 Form 4 Insider Report for Matinas BioPharma Holdings, Inc. (MTNB)

Role
Director
Signature
/s/_Keith A. Kucinski, attorney-in fact for Matthew Wikler
Issuer symbol
MTNB
Transactions as of
30 Sep 2021
Net transactions value
$0
Form type
4
Filing time
01 Oct 2021, 18:03:43 UTC
Previous filing
01 Jul 2021
Next filing
02 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MTNB Common Stock Award $0 +6,106 +2.2% $0.000000 282,613 30 Sep 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 30, 2021, the Reporting Person was issued 6,106 shares of common stock par value $.0001 per share pursuant to the Issuer's Amended and Restated 2013 Equity Compensation Plan. Such shares vest immediately upon grant.